Dr Ajay K Agrawal PhD
Director of Business Development
Dr Ajay Agrawal is the Director of Business Development. He has extensive experience in the biotech and pharmaceutical industry worldwide. Dr Agrawal was a founder of polyMASC Pharmaceuticals plc, London, the first UK biotech company, spun out from a university that was directly listed on AIM, raising approximately $40 million in 1995, and subsequently merged with a NASDAQ-listed company, Valentis Inc (USA) in 1999 to become one of the biggest companies in the delivery of biologics at that time.
He is currently a non-executive director and chairman of the remuneration and vice chairman of audit committees of ImmuPharma plc, AIM-listed biotech company in London with operations in its subsidiaries in France and Switzerland. He currently sits on the editorial advisory board of four international journals from the USA.